Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 3
1974 5
1975 8
1976 9
1977 9
1978 8
1979 5
1980 8
1981 7
1982 12
1983 12
1984 10
1985 8
1986 7
1987 11
1988 16
1989 29
1990 16
1991 24
1992 7
1993 10
1994 9
1995 13
1996 10
1997 11
1998 9
1999 11
2000 7
2001 6
2002 11
2003 13
2004 13
2005 11
2006 14
2007 15
2008 11
2009 5
2010 3
2011 7
2012 8
2013 12
2014 9
2015 5
2016 5
2017 7
2018 5
2019 1
2020 2
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

443 results
Results by year
Filters applied: . Clear all
Page 1
The challenge of biosimilars.
Mellstedt H, Niederwieser D, Ludwig H. Mellstedt H, et al. Ann Oncol. 2008 Mar;19(3):411-9. doi: 10.1093/annonc/mdm345. Epub 2007 Sep 14. Ann Oncol. 2008. PMID: 17872902 Free article. Review.
Biosimilars - terms of use.
Declerck P, Mellstedt H, Danese S. Declerck P, et al. Among authors: mellstedt h. Curr Med Res Opin. 2015 Dec;31(12):2325-30. doi: 10.1185/03007995.2015.1098601. Epub 2015 Oct 27. Curr Med Res Opin. 2015. PMID: 26397731 Review.
Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules.
Hojjat-Farsangi M, Moshfegh A, Schultz J, Norin M, Olin T, Österborg A, Mellstedt H. Hojjat-Farsangi M, et al. Among authors: mellstedt h. Handb Exp Pharmacol. 2021;269:75-99. doi: 10.1007/164_2021_535. Handb Exp Pharmacol. 2021. PMID: 34490515
European Perspective on Biosimilars.
Mellstedt H. Mellstedt H. J Oncol Pract. 2017 Sep;13(9_suppl):15s-16s. doi: 10.1200/JOP.2017.025569. J Oncol Pract. 2017. PMID: 28898594 No abstract available.
Ibrutinib-A double-edge sword in cancer and autoimmune disorders.
Kokhaei P, Jadidi-Niaragh F, Sotoodeh Jahromi A, Osterborg A, Mellstedt H, Hojjat-Farsangi M. Kokhaei P, et al. Among authors: mellstedt h. J Drug Target. 2016;24(5):373-85. doi: 10.3109/1061186X.2015.1086357. Epub 2015 Sep 11. J Drug Target. 2016. PMID: 26362595 Review.
Therapeutic vaccines for cancer: an overview of clinical trials.
Melero I, Gaudernack G, Gerritsen W, Huber C, Parmiani G, Scholl S, Thatcher N, Wagstaff J, Zielinski C, Faulkner I, Mellstedt H. Melero I, et al. Among authors: mellstedt h. Nat Rev Clin Oncol. 2014 Sep;11(9):509-24. doi: 10.1038/nrclinonc.2014.111. Epub 2014 Jul 8. Nat Rev Clin Oncol. 2014. PMID: 25001465 Review.
Cancer initiatives in developing countries.
Mellstedt H. Mellstedt H. Ann Oncol. 2006 Jun;17 Suppl 8:viii24-viii31. doi: 10.1093/annonc/mdl984. Ann Oncol. 2006. PMID: 16801336 Free article. Review.
Monoclonal antibodies in human cancer.
Mellstedt H. Mellstedt H. Drugs Today (Barc). 2003;39 Suppl C:1-16. Drugs Today (Barc). 2003. PMID: 14988743 Review.
443 results